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SUMMARY. Inhibition action of propylene glycol (PG) on the antifungal activity of fluconazole has been
investigated. PG was used as cosolvent and penetration enhancer in different solutions and topical dosage
forms. The interaction was analyzed by comparing with Transcutol P® (TCL), another cosolvent and pen-
etration enhancer. Solubility of the drug was evaluated in aqueous solutions containing PG or TCL and
the crystallized drug was studied by both DSC and FTIR. Solutions of the drug in the solvents were stud-
ied by FTIR and UV spectroscopy. Antifungal activity was determined for solutions with several concen-
trations of PG/TCL and in dosage forms with PG 10 %. Candida albicans was used as a model fungus and
a procedure with standardized inoculum concentration was used. Results showed lower antifungal activity
of fluconazole solutions and topical dosage forms when propylene glycol is included. Although crystalliza-
tion is faster in PG solutions, solubility proved not to be the cause, but changes in FTIR spectra suggested
that different hydrogen bond formation could explain the decrease in activity.
